Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology
Cristina P. Vieira
Abstract
Bentham Science - STM publisher of online and print journals, and related print/online book series. Bentham Science answers the information needs of scientists in the fields of pharmaceutical, biomedical, medical, engineering, technology, computer and social sciences.
Topics & Concepts
Downregulation and upregulationCoronavirus disease 2019 (COVID-19)EnzymeImmunopathologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Angiotensin-converting enzyme 22019-20 coronavirus outbreakReceptorBetacoronavirusPeptidyl-Dipeptidase AVirologyAngiotensin-converting enzymeRenin–angiotensin systemMedicineImmunologyChemistryInternal medicineGeneBiochemistryEnzyme inhibitorOutbreakBlood pressureInfectious disease (medical specialty)DiseaseCOVID-19 Clinical Research StudiesCancer, Stress, Anesthesia, and Immune ResponseDiverse Scientific Research Studies